Bioliberty
Bioliberty is a company focused on transforming physical and occupational therapy through advancements in soft robotics, gamified therapy, and AI insights. Their core product, Lifehub Clinic, aims to help clinicians deliver more therapy to more patients with better outcomes by providing a seamless system of soft robotic wearables and an advanced AI platform. The system is designed for both inpatient and outpatient settings, offering tailored therapy modes, efficient session delivery, and portability across facilities. Key products include Lifehub (the central control unit), Lifeglov (a soft robotic glove for upper extremity therapy), and Lifemind (a clinician-facing interface for therapy data). The company was founded in 2020 by Rowan Armstrong, Ross O’Hanlon, Conan Bradley, and Shéa Quinn, who were inspired by a personal experience to create tools that help individuals regain mobility and independence. Bioliberty has secured a fundamental patent, completed a pre-seed raise, and initiated a clinical study with Mount Sinai health system, with its Lifehub and Lifeglov being FDA registered as of December 2024. They have headquarters in Edinburgh, UK, and Boston, US, positioning them within strong innovation ecosystems.
Bioliberty
Bioliberty is a company focused on transforming physical and occupational therapy through advancements in soft robotics, gamified therapy, and AI insights. Their core product, Lifehub Clinic, aims to help clinicians deliver more therapy to more patients with better outcomes by providing a seamless system of soft robotic wearables and an advanced AI platform. The system is designed for both inpatient and outpatient settings, offering tailored therapy modes, efficient session delivery, and portability across facilities. Key products include Lifehub (the central control unit), Lifeglov (a soft robotic glove for upper extremity therapy), and Lifemind (a clinician-facing interface for therapy data). The company was founded in 2020 by Rowan Armstrong, Ross O’Hanlon, Conan Bradley, and Shéa Quinn, who were inspired by a personal experience to create tools that help individuals regain mobility and independence. Bioliberty has secured a fundamental patent, completed a pre-seed raise, and initiated a clinical study with Mount Sinai health system, with its Lifehub and Lifeglov being FDA registered as of December 2024. They have headquarters in Edinburgh, UK, and Boston, US, positioning them within strong innovation ecosystems.